NZ554629A - Nutritional composition comprising omega 3 fatty acids, for feeding infants whose mother suffered from diabetes or obesity - Google Patents
Nutritional composition comprising omega 3 fatty acids, for feeding infants whose mother suffered from diabetes or obesityInfo
- Publication number
- NZ554629A NZ554629A NZ554629A NZ55462905A NZ554629A NZ 554629 A NZ554629 A NZ 554629A NZ 554629 A NZ554629 A NZ 554629A NZ 55462905 A NZ55462905 A NZ 55462905A NZ 554629 A NZ554629 A NZ 554629A
- Authority
- NZ
- New Zealand
- Prior art keywords
- lipid
- composition
- dha
- dpan
- epa
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 112
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 20
- 235000020660 omega-3 fatty acid Nutrition 0.000 title claims abstract description 15
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 7
- 208000008589 Obesity Diseases 0.000 title claims abstract description 4
- 235000020824 obesity Nutrition 0.000 title claims abstract description 4
- 229940012843 omega-3 fatty acid Drugs 0.000 title 1
- 239000006014 omega-3 oil Substances 0.000 title 1
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims abstract description 120
- 150000002632 lipids Chemical class 0.000 claims abstract description 87
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims abstract description 71
- 229940090949 docosahexaenoic acid Drugs 0.000 claims abstract description 62
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims abstract description 56
- YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 claims abstract description 55
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims abstract description 54
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims abstract description 54
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims abstract description 54
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims abstract description 50
- 235000021294 Docosapentaenoic acid Nutrition 0.000 claims abstract description 34
- 235000021342 arachidonic acid Nutrition 0.000 claims abstract description 28
- 229940114079 arachidonic acid Drugs 0.000 claims abstract description 28
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims abstract description 21
- 229960004232 linoleic acid Drugs 0.000 claims abstract description 16
- 235000020778 linoleic acid Nutrition 0.000 claims abstract description 14
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims abstract description 14
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 claims abstract description 13
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 10
- 230000035935 pregnancy Effects 0.000 claims abstract description 10
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 claims abstract description 9
- YUFFSWGQGVEMMI-JLNKQSITSA-M (7Z,10Z,13Z,16Z,19Z)-docosapentaenoate Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC([O-])=O YUFFSWGQGVEMMI-JLNKQSITSA-M 0.000 claims abstract description 9
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 claims abstract description 9
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 claims abstract description 9
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 6
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 6
- 239000007788 liquid Substances 0.000 claims abstract description 5
- 235000013311 vegetables Nutrition 0.000 claims abstract description 5
- 206010033307 Overweight Diseases 0.000 claims abstract description 3
- 241000024188 Andala Species 0.000 claims abstract 2
- 235000013350 formula milk Nutrition 0.000 claims description 8
- 239000002773 nucleotide Substances 0.000 claims description 7
- 125000003729 nucleotide group Chemical group 0.000 claims description 7
- 239000000835 fiber Substances 0.000 claims description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 4
- 239000008101 lactose Substances 0.000 claims description 4
- 230000035764 nutrition Effects 0.000 claims description 4
- 235000020664 gamma-linolenic acid Nutrition 0.000 claims description 3
- 235000020978 long-chain polyunsaturated fatty acids Nutrition 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 239000002777 nucleoside Substances 0.000 claims description 3
- 125000003835 nucleoside group Chemical group 0.000 claims description 3
- 235000019482 Palm oil Nutrition 0.000 claims description 2
- 235000019486 Sunflower oil Nutrition 0.000 claims description 2
- 239000010473 blackcurrant seed oil Substances 0.000 claims description 2
- 235000021324 borage oil Nutrition 0.000 claims description 2
- 239000000828 canola oil Substances 0.000 claims description 2
- 235000019519 canola oil Nutrition 0.000 claims description 2
- 239000003240 coconut oil Substances 0.000 claims description 2
- 235000019864 coconut oil Nutrition 0.000 claims description 2
- 235000008524 evening primrose extract Nutrition 0.000 claims description 2
- 239000010475 evening primrose oil Substances 0.000 claims description 2
- 229940089020 evening primrose oil Drugs 0.000 claims description 2
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 claims description 2
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 claims description 2
- 229960002733 gamolenic acid Drugs 0.000 claims description 2
- 239000002540 palm oil Substances 0.000 claims description 2
- 239000003549 soybean oil Substances 0.000 claims description 2
- 235000012424 soybean oil Nutrition 0.000 claims description 2
- 239000002600 sunflower oil Substances 0.000 claims description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 1
- 229960001231 choline Drugs 0.000 claims 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims 1
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 1
- 239000011707 mineral Substances 0.000 claims 1
- 235000010755 mineral Nutrition 0.000 claims 1
- 229960003080 taurine Drugs 0.000 claims 1
- 239000011573 trace mineral Substances 0.000 claims 1
- 235000013619 trace mineral Nutrition 0.000 claims 1
- 239000011782 vitamin Substances 0.000 claims 1
- 235000013343 vitamin Nutrition 0.000 claims 1
- 229940088594 vitamin Drugs 0.000 claims 1
- 229930003231 vitamin Natural products 0.000 claims 1
- 239000011701 zinc Substances 0.000 claims 1
- 229910052725 zinc Inorganic materials 0.000 claims 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 48
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 33
- 229960004488 linolenic acid Drugs 0.000 description 32
- 239000002243 precursor Substances 0.000 description 17
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 16
- 235000014113 dietary fatty acids Nutrition 0.000 description 14
- 229930195729 fatty acid Natural products 0.000 description 14
- 239000000194 fatty acid Substances 0.000 description 14
- 150000004665 fatty acids Chemical class 0.000 description 14
- 235000020256 human milk Nutrition 0.000 description 11
- 210000004251 human milk Anatomy 0.000 description 8
- 235000014633 carbohydrates Nutrition 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- 210000004556 brain Anatomy 0.000 description 6
- 208000030159 metabolic disease Diseases 0.000 description 6
- 125000005456 glyceride group Chemical group 0.000 description 5
- 238000000034 method Methods 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 3
- HOBAELRKJCKHQD-QNEBEIHSSA-N dihomo-γ-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HOBAELRKJCKHQD-QNEBEIHSSA-N 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000010348 incorporation Methods 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- HOBAELRKJCKHQD-UHFFFAOYSA-N (8Z,11Z,14Z)-8,11,14-eicosatrienoic acid Natural products CCCCCC=CCC=CCC=CCCCCCCC(O)=O HOBAELRKJCKHQD-UHFFFAOYSA-N 0.000 description 2
- YZZVIKDAOTXDEB-UHFFFAOYSA-N 4-(aminomethyl)-3-(5,7-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)-1h-imidazole-2-thione Chemical compound NCC1=CNC(=S)N1C1CC2=CC(F)=CC(F)=C2CC1 YZZVIKDAOTXDEB-UHFFFAOYSA-N 0.000 description 2
- TXXYYOUBDOAQDT-UHFFFAOYSA-N 4-nitro-1-(phenylmethoxymethyl)imidazole Chemical compound C1=NC([N+](=O)[O-])=CN1COCC1=CC=CC=C1 TXXYYOUBDOAQDT-UHFFFAOYSA-N 0.000 description 2
- CKLJMWTZIZZHCS-UWTATZPHSA-N D-aspartic acid Chemical compound OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 2
- 230000004641 brain development Effects 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 229940013317 fish oils Drugs 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000021125 infant nutrition Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 230000007472 neurodevelopment Effects 0.000 description 2
- 230000000926 neurological effect Effects 0.000 description 2
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 2
- 229940033080 omega-6 fatty acid Drugs 0.000 description 2
- AVKOENOBFIYBSA-WMPRHZDHSA-N (4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O AVKOENOBFIYBSA-WMPRHZDHSA-N 0.000 description 1
- YUFFSWGQGVEMMI-UHFFFAOYSA-N (7Z,10Z,13Z,16Z,19Z)-7,10,13,16,19-docosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCCCC(O)=O YUFFSWGQGVEMMI-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 235000021298 Dihomo-γ-linolenic acid Nutrition 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241001497337 Euscorpius gamma Species 0.000 description 1
- GRSZFWQUAKGDAV-KQYNXXCUSA-L IMP(2-) Chemical compound O[C@@H]1[C@H](O)[C@@H](COP([O-])([O-])=O)O[C@H]1N1C(N=CNC2=O)=C2N=C1 GRSZFWQUAKGDAV-KQYNXXCUSA-L 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 206010051606 Necrotising colitis Diseases 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- 208000024330 bloating Diseases 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- XIVFQYWMMJWUCD-UHFFFAOYSA-N dihydrophaseic acid Natural products C1C(O)CC2(C)OCC1(C)C2(O)C=CC(C)=CC(O)=O XIVFQYWMMJWUCD-UHFFFAOYSA-N 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 1
- 150000003271 galactooligosaccharides Chemical class 0.000 description 1
- 210000004884 grey matter Anatomy 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000003933 intellectual function Effects 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 208000004995 necrotizing enterocolitis Diseases 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 201000006195 perinatal necrotizing enterocolitis Diseases 0.000 description 1
- 150000003904 phospholipids Chemical group 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 230000025366 tissue development Effects 0.000 description 1
- 125000005457 triglyceride group Chemical group 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Botany (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pediatric Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Edible Oils And Fats (AREA)
- Dairy Products (AREA)
- Medicinal Preparation (AREA)
- Fats And Perfumes (AREA)
- Seeds, Soups, And Other Foods (AREA)
- Bakery Products And Manufacturing Methods Therefor (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04026825A EP1656839A1 (en) | 2004-11-11 | 2004-11-11 | Nutrition containing lipid blend |
| PCT/EP2005/012122 WO2006050975A1 (en) | 2004-11-11 | 2005-11-11 | Nutrition containing fat blend |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ554629A true NZ554629A (en) | 2010-09-30 |
Family
ID=34927339
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ554629A NZ554629A (en) | 2004-11-11 | 2005-11-11 | Nutritional composition comprising omega 3 fatty acids, for feeding infants whose mother suffered from diabetes or obesity |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US8053471B2 (enExample) |
| EP (3) | EP1656839A1 (enExample) |
| JP (1) | JP2008519796A (enExample) |
| CN (2) | CN101052316B (enExample) |
| AT (1) | ATE457656T1 (enExample) |
| AU (1) | AU2005303903B2 (enExample) |
| BR (1) | BRPI0517479B1 (enExample) |
| CA (1) | CA2586946C (enExample) |
| DE (1) | DE602005019452D1 (enExample) |
| DK (1) | DK1809125T3 (enExample) |
| ES (1) | ES2341355T3 (enExample) |
| NZ (1) | NZ554629A (enExample) |
| PL (1) | PL1809125T3 (enExample) |
| PT (1) | PT1809125E (enExample) |
| RU (1) | RU2402927C2 (enExample) |
| SG (1) | SG143274A1 (enExample) |
| UA (1) | UA89207C2 (enExample) |
| WO (1) | WO2006050975A1 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1656839A1 (en) | 2004-11-11 | 2006-05-17 | N.V. Nutricia | Nutrition containing lipid blend |
| CA2645645C (en) | 2005-05-23 | 2015-07-14 | Massachusetts Institute Of Technology | Compositions containing pufa and methods of use thereof |
| WO2007058523A1 (en) * | 2005-11-17 | 2007-05-24 | N.V. Nutricia | Composition with docosapentaenoic acid |
| WO2008054192A1 (en) * | 2006-11-02 | 2008-05-08 | N.V. Nutricia | Use of nutritional compositions for preventing disorders |
| BRPI0620465A2 (pt) * | 2005-12-23 | 2011-11-16 | Nutricia Nv | uso de uma composição |
| WO2008054193A1 (en) * | 2006-11-02 | 2008-05-08 | N.V. Nutricia | Nutritional products that comprise saccharide oligomers |
| WO2009002145A1 (en) | 2007-06-26 | 2008-12-31 | N.V. Nutricia | Lipid composition for improving function of brain functioning |
| WO2009002166A1 (en) | 2007-06-26 | 2008-12-31 | N.V. Nutricia | Improving memory in subjects with mini-mental state examination of 24-26 |
| WO2009002146A1 (en) | 2007-06-26 | 2008-12-31 | N.V. Nutricia | Supporting activities of daily living |
| WO2009002148A1 (en) | 2007-06-27 | 2008-12-31 | N.V. Nutricia | Food composition for prodromal dementia patients |
| CN100542411C (zh) * | 2007-09-24 | 2009-09-23 | 张国浩 | 一种含ω-3多不饱和脂肪酸的营养均衡调和油及其生产方法 |
| BRPI0822111B8 (pt) | 2007-12-20 | 2021-05-25 | Nutricia Nv | composição líquida, e, uso de uma composição líquida |
| US20090264520A1 (en) * | 2008-04-21 | 2009-10-22 | Asha Lipid Sciences, Inc. | Lipid-containing compositions and methods of use thereof |
| US9149452B2 (en) * | 2009-04-20 | 2015-10-06 | Women's & Children's Health Research Institute Inc. | Methods and compositions for promoting the neurological development of an infant |
| JP5335601B2 (ja) * | 2009-07-30 | 2013-11-06 | ビーンスターク・スノー株式会社 | 栄養組成物 |
| WO2012087113A1 (en) * | 2010-12-24 | 2012-06-28 | N.V. Nutricia | Improved nutritional tablet |
| EP2797432A2 (en) | 2011-12-27 | 2014-11-05 | Abbott Laboratories | Use of reduced calorie infant formula containing nucleotides and/or carotenoids for reducing adverse health effects later in life |
| WO2013192109A1 (en) | 2012-06-17 | 2013-12-27 | Matinas Biopharma, Inc. | Omega-3 pentaenoic acid compositions and methods of use |
| EP2968246A4 (en) * | 2013-03-13 | 2016-08-03 | Matinas Biopharma Inc | OMEGA-3-PENTAIC ACID COMPOSITIONS AND METHODS OF USE |
| US8728546B1 (en) | 2013-03-15 | 2014-05-20 | Swing Aerobics Licensing, Inc. | Medicament for treatment of cancer, cardiovascular diseases and inflammation |
| FR3045069B1 (fr) * | 2015-12-14 | 2019-01-25 | Metabolium | Procede d'enrichissement de protistes en lipides riches en acides gras polyinsatures, plus particulierement de classe omega 3, et sa mise en oeuvre pour la production de ces lipides |
| WO2017183970A1 (en) * | 2016-04-18 | 2017-10-26 | N.V. Nutricia | Linoleic acid and alpha-li nolenic acid for use for reducing early-life stress induced cognitive decline/reduction in neurogenesis |
| US20190060268A1 (en) * | 2017-08-25 | 2019-02-28 | Increnovo, LLC | Compositions and methods for preventing, alleviating, and treating neurological injury following head trauma |
| JP7769607B2 (ja) * | 2019-11-08 | 2025-11-13 | アボット・ラボラトリーズ | ウシ乳汁単離粉末状エクソソーム、栄養組成物および方法 |
| WO2023232882A1 (en) | 2022-05-31 | 2023-12-07 | N.V. Nutricia | Infant formula for improving cognitive development |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4670285A (en) * | 1982-08-06 | 1987-06-02 | The University Of Toronto Innovations Foundation | Infant formula |
| ES2033193B1 (es) * | 1990-10-30 | 1994-01-16 | Ganadera Union Ind Agro | Mezcla grasa para nutricion infantil y de adultos. |
| KR940003473A (ko) * | 1992-08-14 | 1994-03-12 | 이순목 | n-3 지방산이 축적된 우유 및 우유용 사료조성물 |
| NL9401644A (nl) * | 1994-10-06 | 1996-05-01 | Friesland Brands Bv | Voedingsmiddel voor zwangere en lacterende vrouwen |
| WO1996033263A1 (en) * | 1995-04-17 | 1996-10-24 | JAPAN, represented by DIRECTOR-GENERAL OF AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY | Novel microorganisms capable of producing highly unsaturated fatty acids and process for producing highly unsaturated fatty acids by using the microorganisms |
| KR100277808B1 (ko) * | 1995-05-30 | 2001-01-15 | 다카후미 이시하라 | 가금난으로부터 수득된 고도 불포화 지방산 함량이 높은 지질 및 이의 제조방법 |
| ATE221324T1 (de) * | 1996-11-20 | 2002-08-15 | Nutricia Nv | Fette enthaltende ernährungszusammensetzung zur behandlung des stoffwechselssyndroms |
| ES2219871T3 (es) * | 1997-02-21 | 2004-12-01 | Abbott Laboratories | Procedimiento y composiciones que sirven para limitar la frecuencia de la enterocolitis necrotizante del recien nacido. |
| CN1191828C (zh) * | 1997-03-27 | 2005-03-09 | 布里斯托尔-迈尔斯斯奎布公司 | 二十二碳六烯酸和花生四烯酸促进不足月婴儿生长的用途 |
| US6432684B1 (en) * | 1997-04-11 | 2002-08-13 | Abbott Laboratories | Human desaturase gene and uses thereof |
| PT893064E (pt) * | 1997-07-22 | 2003-04-30 | Nestle Sa | Composicao lipidica para formulacao infantil e processo de preparacao |
| AU6503699A (en) * | 1998-10-05 | 2000-04-26 | Abbott Laboratories | Altered fatty acid biosynthesis in insect cells using delta five desaturase |
| US6596302B2 (en) * | 2000-04-13 | 2003-07-22 | Abbott Laboratories | Infant formulas containing long-chain polyunsaturated fatty acids and uses thereof |
| ITBO20000471A1 (it) | 2000-07-31 | 2002-01-31 | Vieri Ridolfi | Dispositivo di supporto per prodotti da fumo particolarmente sigarette . |
| DE10057976B4 (de) | 2000-11-22 | 2005-02-03 | Südzucker AG Mannheim/Ochsenfurt | Verfahren zur Herstellung von Pektinhydrolyseprodukten |
| EP1392623A4 (en) * | 2001-05-14 | 2005-05-04 | Martek Biosciences Corp | PREPARATION AND USE OF A POLAR LIPID RICH FRACTION CONTAINING HIGHLY UNSATURATED OMEGA-3 AND / OR OMEGA-6 FATTY ACIDS FROM MICROBES, SEEDS OF GENETICALLY MODIFIED PLANTS AND MARINE ORGANISMS |
| US20040209953A1 (en) * | 2002-12-06 | 2004-10-21 | Wai Lee Theresa Siu-Ling | Glyceride compositions and methods of making and using same |
| GB0308104D0 (en) * | 2003-04-08 | 2003-05-14 | Novartis Nutrition Ag | Organic compounds |
| EP1656839A1 (en) | 2004-11-11 | 2006-05-17 | N.V. Nutricia | Nutrition containing lipid blend |
-
2004
- 2004-11-11 EP EP04026825A patent/EP1656839A1/en not_active Withdrawn
-
2005
- 2005-11-11 PT PT05813382T patent/PT1809125E/pt unknown
- 2005-11-11 UA UAA200706381A patent/UA89207C2/ru unknown
- 2005-11-11 ES ES05813382T patent/ES2341355T3/es not_active Expired - Lifetime
- 2005-11-11 WO PCT/EP2005/012122 patent/WO2006050975A1/en not_active Ceased
- 2005-11-11 DK DK05813382.8T patent/DK1809125T3/da active
- 2005-11-11 RU RU2007121665/13A patent/RU2402927C2/ru not_active IP Right Cessation
- 2005-11-11 CA CA2586946A patent/CA2586946C/en not_active Expired - Fee Related
- 2005-11-11 AU AU2005303903A patent/AU2005303903B2/en not_active Ceased
- 2005-11-11 BR BRPI0517479-1A patent/BRPI0517479B1/pt not_active IP Right Cessation
- 2005-11-11 EP EP10153682A patent/EP2191733A1/en not_active Withdrawn
- 2005-11-11 JP JP2007540596A patent/JP2008519796A/ja active Pending
- 2005-11-11 US US11/666,990 patent/US8053471B2/en not_active Expired - Fee Related
- 2005-11-11 PL PL05813382T patent/PL1809125T3/pl unknown
- 2005-11-11 CN CN2005800374672A patent/CN101052316B/zh not_active Expired - Fee Related
- 2005-11-11 CN CN201210004226.XA patent/CN102511818B/zh not_active Expired - Fee Related
- 2005-11-11 SG SG200803936-4A patent/SG143274A1/en unknown
- 2005-11-11 NZ NZ554629A patent/NZ554629A/en not_active IP Right Cessation
- 2005-11-11 DE DE602005019452T patent/DE602005019452D1/de not_active Expired - Lifetime
- 2005-11-11 EP EP05813382A patent/EP1809125B1/en not_active Expired - Lifetime
- 2005-11-11 AT AT05813382T patent/ATE457656T1/de active
-
2011
- 2011-10-03 US US13/251,399 patent/US8729123B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DK1809125T3 (da) | 2010-06-07 |
| US20080269330A1 (en) | 2008-10-30 |
| CA2586946C (en) | 2014-09-30 |
| BRPI0517479A (pt) | 2008-10-07 |
| DE602005019452D1 (de) | 2010-04-01 |
| WO2006050975A1 (en) | 2006-05-18 |
| ATE457656T1 (de) | 2010-03-15 |
| AU2005303903A1 (en) | 2006-05-18 |
| RU2402927C2 (ru) | 2010-11-10 |
| CA2586946A1 (en) | 2006-05-18 |
| EP1809125B1 (en) | 2010-02-17 |
| BRPI0517479B1 (pt) | 2015-06-09 |
| SG143274A1 (en) | 2008-06-27 |
| US8053471B2 (en) | 2011-11-08 |
| EP1809125A1 (en) | 2007-07-25 |
| CN101052316B (zh) | 2012-02-22 |
| RU2007121665A (ru) | 2008-12-20 |
| PL1809125T3 (pl) | 2010-07-30 |
| US8729123B2 (en) | 2014-05-20 |
| CN102511818A (zh) | 2012-06-27 |
| CN102511818B (zh) | 2014-12-24 |
| EP2191733A1 (en) | 2010-06-02 |
| US20120027885A1 (en) | 2012-02-02 |
| JP2008519796A (ja) | 2008-06-12 |
| EP1656839A1 (en) | 2006-05-17 |
| ES2341355T3 (es) | 2010-06-18 |
| UA89207C2 (ru) | 2010-01-11 |
| PT1809125E (pt) | 2010-05-20 |
| AU2005303903B2 (en) | 2012-05-31 |
| CN101052316A (zh) | 2007-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8729123B2 (en) | Nutrition containing fat blend | |
| Sanders | Essential fatty acid requirements of vegetarians in pregnancy, lactation, and infancy | |
| Lapillonne et al. | Lipid needs of preterm infants: updated recommendations | |
| US20090054329A1 (en) | Composition with docosapentaenoic acid | |
| CA2648826C (en) | Preterm formula | |
| RU2558853C2 (ru) | Эффекты метаболического импринтинга структурированных липидов | |
| Lapillonne | Enteral and parenteral lipid requirements of preterm infants | |
| US20150245644A1 (en) | Composition of nutrients and bioactive substances which promote growth and reduce intolerance and side effects in premature infants | |
| CN102368913A (zh) | 降低肥胖的风险 | |
| Briend et al. | Lipid intake in children under 3 years of age in France. A position paper by the Committee on Nutrition of the French Society of Paediatrics | |
| CN115104731B (zh) | 营养组合物以及包含所述营养组合物的食品 | |
| JP2001029010A (ja) | 栄養組成物 | |
| Elvevoll et al. | The emerging importance of dietary lipids, quantity and quality, in the global disease burden: the potential of aquatic resources | |
| Uauy et al. | Requirements for long-chain polyunsaturated fatty acids in the preterm infant | |
| Hendricks et al. | Significance of milk fat in infant formulae | |
| Mena et al. | Fats | |
| Delplanque et al. | Brain docosahexaenoic acid (DHA) levels of young rats are related to alpha-linolenic acid (ALA) levels and fat matrix of the diet: impact of dairy fat | |
| Zhang et al. | Health Effects of Docosahexanoic Acid (DHA)‒Enriched Eggs | |
| Hartmann et al. | Longitudinal measures of visual acuity in full-term human infants fed different dietary fatty acids | |
| Goldman | The role of long chain polyunsaturated fatty acids in infant nutrition | |
| Freitas et al. | DHAid™–The vegetarian source | |
| CONNOR et al. | Importance of Dietary Omega-3 Fatty Acids in Retinal Function |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 NOV 2016 BY PAVIS EG Effective date: 20151102 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 NOV 2017 BY PAVIS GMBH Effective date: 20161028 |
|
| LAPS | Patent lapsed |